Disparities in Survival Among Patients With Pancreatic Neuroendocrine Tumor Using the National Cancer Database: Effects of Insurance Status and Treatment Facility

HPB- United Kingdom

doi 10.1016/j.hpb.2019.03.268

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Dissecting Racial Disparities in the Treatment of Patients With Locoregional Pancreatic Cancer

Cancer
Cancer ResearchOncology
2010English

Insulin-Dependence Predicts Disease-Specific Survival in Pancreatic Neuroendocrine Tumor Patients

HPB
HepatologyGastroenterology
2019English

Race, Socioeconomic Status, Treatment, and Survival Time Among Pancreatic Cancer Cases in California

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer

Journal of Surgical Research
Surgery
2020English

Combined Treatment of Patients With Pancreatic Neuroendocrine Carcinomas

Annals of HPB Surgery
HepatologySurgeryGastroenterology
2018English

Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer

Cancer Journal
Cancer ResearchOncology
2015English

Prognosis of Patients With Neuroendocrine Tumor: A SEER Database Analysis

Cancer Management and Research
Oncology
2018English

Racial Disparities in Surgical Resection and Survival Among Elderly Patients With Poor Prognosis Cancer

Journal of the American College of Surgeons
Surgery
2013English

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

JAMA network open
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy